Skip to main navigation Skip to search Skip to main content

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer

  • David Bender
  • , Michael W. Sill
  • , Heather A. Lankes
  • , Henry D. Reyes
  • , Christopher J. Darus
  • , James E. Delmore
  • , Jacob Rotmensch
  • , Heidi J. Gray
  • , Robert S. Mannel
  • , Jeanne M. Schilder
  • , Mark I. Hunter
  • , Carolyn K. McCourt
  • , Megan I. Samuelson
  • , Kimberly K. Leslie
  • University of Iowa
  • Roswell Park Cancer Institute
  • Maine Medical Center
  • University of Kansas
  • Rush University Medical Center
  • University of Washington
  • University of Oklahoma
  • Indiana University
  • University of Missouri
  • Brown University

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGynecologic Oncology
Volume138
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this